Physiomics (PYC) RNS Announcements

Add to Alert list
Date Time Source Announcement
08 Jul 2019 07:00 AM
RNS
Agreement with Bicycle and Cancer Research UK
02 Jul 2019 01:30 PM
RNS
Holding(s) in Company
28 Jun 2019 07:00 AM
RNS
Contract Award
31 May 2019 07:00 AM
RNS
Change of Adviser
14 May 2019 07:00 AM
RNS
Innovate UK Award Project
03 May 2019 12:00 PM
RNS
Physiomics participates at NIHR event
30 Apr 2019 02:00 PM
RNS
Conference attendance and presentation
27 Mar 2019 01:00 PM
RNS
Issue of Options
26 Mar 2019 01:00 PM
RNS
AIM Rule 26 Website Change
20 Mar 2019 07:00 AM
RNS
Conference Attendance and Presentation
21 Feb 2019 07:00 AM
RNS
Interim Results
07 Jan 2019 07:00 AM
RNS
Conference Attendance
03 Jan 2019 07:00 AM
RNS
Strategic Collaboration
17 Dec 2018 07:00 AM
RNS
Renewal of Agreement with Merck
20 Nov 2018 12:56 PM
RNS
Result of AGM
15 Oct 2018 01:00 PM
RNS
Dispatch of Annual Report and Shareholder Circular
08 Oct 2018 07:00 AM
RNS
Final Results for the Year Ended 30 June 2018
09 Aug 2018 07:00 AM
RNS
Contract award
02 Jul 2018 01:57 PM
RNS
Physiomics Expands Technical Team
21 Jun 2018 07:00 AM
RNS
Trading Update
11 Jun 2018 04:05 PM
RNS
Updated Website
23 May 2018 07:00 AM
RNS
Placing
26 Apr 2018 11:06 AM
RNS
Contract Award
06 Apr 2018 02:40 PM
RNS
Director/PDMR Shareholding
04 Apr 2018 07:00 AM
RNS
Physiomics to Present at AACR Annual Meeting
27 Mar 2018 05:23 PM
RNS
Issue of Options
14 Mar 2018 07:00 AM
RNS
Award of New Innovate UK Grant
12 Mar 2018 07:00 AM
RNS
Completion of Innovate UK Grant Project
19 Feb 2018 07:00 AM
RNS
Interim Results Statement
09 Feb 2018 07:00 AM
RNS
Contract Award
26 Jan 2018 07:00 AM
RNS
New Major Pharmaceutical Client
25 Jan 2018 01:34 PM
RNS
Holding(s) in Company
24 Jan 2018 08:46 AM
RNS
Holding(s) in Company
19 Jan 2018 10:20 AM
RNS
Holding(s) in Company
17 Jan 2018 03:52 PM
RNS
Holding(s) in Company
13 Dec 2017 02:06 PM
RNS
Result of AGM
12 Dec 2017 10:17 AM
RNS
Director Dealing
06 Dec 2017 03:00 PM
RNS
Issue of Equity
30 Nov 2017 01:38 PM
RNS
Share Price Movement
28 Nov 2017 07:00 AM
RNS
Clinical Project Completion and Services Agreement
09 Nov 2017 07:00 AM
RNS
Dispatch of Annual Report and Shareholder Circular
16 Oct 2017 07:00 AM
RNS
Final Results
02 Oct 2017 07:00 AM
RNS
Company Update
31 Jul 2017 07:00 AM
RNS
Two New Pre-Clinical Contracts
06 Jun 2017 07:00 AM
RNS
Physiomics to Attend PAGE 2017
24 May 2017 07:00 AM
RNS
Update: Two Further Extension Projects
05 May 2017 07:00 AM
RNS
Physiomics to Present at BioTrinity 2017
24 Mar 2017 11:15 AM
RNS
Interim Results Statement
11 Jan 2017 07:00 AM
RNS
Company Update
06 Jan 2017 07:00 AM
RNS
Confirmation of Award of Innovate UK Grant

Physiomics plc is a UK-based company that uses mathematical models to help develop cancer treatments and personalized medicine. Services include Virtual Tumor modeling: A combination of proprietary and industry standard technologies that predict the effects of cancer treatments and drugs, Answering R&D questions: Helping clients de-risk drug development and build confidence in a molecule's clinical potential and Predicting therapeutic windows: Helping clients achieve a more quantitative understanding of new molecules.

PYC share price listed at 231p in 2004.

UK 100

Latest directors dealings